< Back to News

Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

JANUARY 28, 2021  |  BIOMED CENTRAL
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04997-6